C07D 215/04
With only hydrogen atoms or radicals containing only hydrogen and carbon atoms
Official title: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
C07D215/04 (With only hydrogen atoms or radicals containing only hydrogen and carbon atoms) appears on 712 US grants and 664 published applications in this corpus.
Search patents in C07D- Granted patents
- 712
- Published applications
- 664
- Assignees
- 474
- Inventors
- 2,508
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 13 | 0 |
| 1977 | 17 | 0 |
| 1978 | 10 | 0 |
| 1979 | 7 | 0 |
| 1980 | 11 | 0 |
| 1981 | 8 | 0 |
| 1982 | 8 | 0 |
| 1983 | 7 | 0 |
| 1984 | 9 | 0 |
| 1985 | 10 | 0 |
| 1986 | 8 | 0 |
| 1987 | 6 | 0 |
| 1988 | 8 | 0 |
| 1989 | 14 | 0 |
| 1990 | 11 | 0 |
| 1991 | 12 | 0 |
| 1992 | 6 | 0 |
| 1993 | 11 | 0 |
| 1994 | 6 | 0 |
| 1995 | 10 | 0 |
| 1996 | 7 | 0 |
| 1997 | 13 | 0 |
| 1998 | 6 | 0 |
| 1999 | 6 | 0 |
| 2000 | 9 | 0 |
| 2001 | 7 | 1 |
| 2002 | 10 | 14 |
| 2003 | 11 | 17 |
| 2004 | 10 | 33 |
| 2005 | 9 | 29 |
| 2006 | 18 | 20 |
| 2007 | 13 | 23 |
| 2008 | 10 | 36 |
| 2009 | 19 | 29 |
| 2010 | 15 | 36 |
| 2011 | 19 | 25 |
| 2012 | 25 | 32 |
| 2013 | 21 | 31 |
| 2014 | 34 | 30 |
| 2015 | 32 | 32 |
| 2016 | 20 | 29 |
| 2017 | 28 | 30 |
| 2018 | 29 | 40 |
| 2019 | 27 | 25 |
| 2020 | 22 | 30 |
| 2021 | 29 | 24 |
| 2022 | 17 | 25 |
| 2023 | 11 | 20 |
| 2024 | 15 | 24 |
| 2025 | 17 | 16 |
| 2026 | 11 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Dihydro-cyclopenta-isoquinoline15 Sep 2026US 12,735,396 B2Ucb Biopharma Srl
- Enantioselective hydrogenation of 4-substituted 1,2-dihydroquinolines in presence of a chiral iridium catalyst and an additive14 Jul 2026US 12,679,808 B2Bayer Aktiengesellschaft
- Organic electroluminescent element and electronic device using same30 Jun 2026US 12,668,739 B2Idemitsu Kosan Co., Ltd.
- Enantioselective hydrogenation of 4-substituted 1,2-dihydroquinolines in presence of a chiral iridium catalyst2 Jun 2026US 12,643,860 B2Bayer Aktiengesellschaft
- Organic Photoredox Catalysts, Compositions, and Conversion Processes24 Sep 2026US 2026/0284647 A1Colorado State University Research Foundation
- Levorphanol prodrugs and processes for making and using them10 Sep 2026US 2026/0265201 A1Zevra Therapeutics, Inc.
- Deubiquitinase inhibitors and methods of use thereof3 Sep 2026US 2026/0258011 A1
- Process for the manufacturing of (6ar,10ar)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4',5':5,6]benzo[1,2-g]quinoline and (4ar,10ar)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol23 Jul 2026US 2026/0209181 A1H. Lundbeck A.S.
- Agent for restoring metal homeostasis25 Jun 2026US 2026/0174721 A1Oxford Antibiotic Group GmbH
Most cited
By later US patents
- Phosphorescent compounds and devices comprising the same1,017US 6,835,469 B2Universal Display Corporation · 2004
- Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds232US 6,670,645 B2E. I. Du Pont de Nemours and Company · 2003
- Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity158US 5,023,341 AAllergan, Inc. · 1991
- Condensed heterocyclic compounds154US 5,037,825 AHoffmann-La Roche Inc. · 1991
- Ethynyl-chroman compounds138US 5,053,523 AAllergan, Inc. · 1991